PMID: 8960502Nov 1, 1996Paper

Intracoronary irradiation: dose response for the prevention of restenosis in swine

International Journal of Radiation Oncology, Biology, Physics
J WeinbergerC Marboe

Abstract

Restenosis after percutaneous transluminal coronary angioplasty represents, in part, a proliferative response of vascular smooth muscle at the site of injury. We have previously shown that high-dose radiation (20 Gy), delivered via an intracoronary 192Ir source, causes focal medial fibrosis and markedly impairs the restenosis process after balloon angioplasty in swine. This study sought to delineate the dose-response characteristics of this effect. Forty juvenile swine underwent coronary angiography; a segment of the left coronary artery was chosen as a target for balloon injury. In 30 swine, a 2 cm ribbon of 192Ir was positioned at the target segment and 20, 15, or 10 Gy were delivered to the vessel wall (10 animals/dose). Subsequently, overdilatation balloon angioplasty was performed at the irradiated segment. In 10 control swine, overdilatation balloon angioplasty was performed without previous irradiation. Thirty-eight animals survived until sacrifice at 30 +/- 3 days. Histopathological analysis was performed by a pathologist in a blinded manner. The area of maximal luminal compromise within the target segment was analyzed via computer-assisted planimetry. Neointimal area was decreased by 71.4% at 20 Gy and by 58.3% at 15 G...Continue Reading

References

Sep 1, 1992·Journal of the American College of Cardiology·T HinoharaJ B Simpson
Apr 11, 1992·Journal of the American College of Cardiology·R S SchwartzD R Holmes
Aug 1, 1992·Journal of the American College of Cardiology·S P KarasS B King
Sep 1, 1991·Circulation·J J PopmaE J Topol
May 1, 1991·Journal of the American College of Cardiology·R M CaliffR S Stack
Nov 1, 1987·Progress in Cardiovascular Diseases·S K ChokshiP Abi-Mansour
Jan 1, 1985·Circulation Research·A W Clowes, S M Schwartz
May 1, 1994·Journal of the American College of Cardiology·J G WiedermannJ Weinberger
Feb 1, 1994·Stroke; a Journal of Cerebral Circulation·S Shimotakahara, M R Mayberg

❮ Previous
Next ❯

Citations

Oct 12, 2000·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·A ManginasD V Cokkinos
Apr 4, 2001·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·G L KałuzaA E Raizner
Sep 19, 2001·Australasian Physical & Engineering Sciences in Medicine·N BoeingM A Ebert
Feb 14, 2007·Cardiovascular and Interventional Radiology·Petros ZampakisDimitrios Siablis
Jun 18, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Veronique L M A CoenPeter C Levendag
Jul 27, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·John C FlickingerL Dade Lunsford
Jan 5, 2002·International Journal of Radiation Oncology, Biology, Physics·Grzegorz L KałuzaAlbert E Raizner
Aug 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Rosanna C ChanRon Waksman
Nov 7, 2002·International Journal of Radiation Oncology, Biology, Physics·Arvind B SoniPaul Okunieff
Nov 7, 1998·International Journal of Radiation Oncology, Biology, Physics·U SchäferN Willich
Oct 19, 1999·International Journal of Radiation Oncology, Biology, Physics·B E PowersE L Gillette
Mar 27, 2001·Journal of the American College of Cardiology·H S KimG S Mintz
Jan 15, 2002·Journal of the American College of Cardiology·Harry C LoweLevon M Khachigian
Jun 9, 1998·Journal of Vascular and Interventional Radiology : JVIR·D A Diamond, T M Vesely
Sep 17, 2003·Cardiovascular Radiation Medicine·Cezary KepkaAdam Witkowski
Sep 17, 2003·Cardiovascular Radiation Medicine·Georgios SianosPatrick W Serruys
Mar 29, 2001·Cardiovascular Radiation Medicine·H I Amols
Mar 29, 2001·Cardiovascular Radiation Medicine·J P WilliamsP Okunieff
Mar 7, 2001·Cardiovascular Radiation Medicine·M C SchellP Rubin
Mar 29, 2001·Cardiovascular Radiation Medicine·H GiapV Massullo
Mar 29, 2001·Cardiovascular Radiation Medicine·H I Amols
Nov 13, 2002·Kidney International·Burnett S KellyPrabir Roy-Chaudhury
Nov 25, 2003·Cancer Biotherapy & Radiopharmaceuticals·Jae Min Jeong, June-Key Chung
Apr 21, 2009·Radiation Protection Dosimetry·Chien-Hau ChuUei-Tyng Lin
Jun 11, 2003·American Journal of Clinical Oncology·Smith Apisarnthanarax, Prakash Chougule
May 25, 2010·Nuclear Medicine Communications·Nalan Alan SelcukIlhami Uslu
Jan 27, 2012·Seminars in Dialysis·Syed Ahmed, Prabir Roy-Chaudhury
Jun 6, 2000·Journal of Neurosurgery·S MaesawaL D Lunsford
Nov 9, 2000·Cardiovascular Radiation Medicine·P FanL B Harrison
Aug 2, 2003·Cardiovascular Radiation Medicine·Dave C Y ChuaGary L Schaer
Oct 13, 2006·Kidney International·S MisraUNKNOWN BRAVO I Investigators
Apr 16, 1998·Journal of Vascular and Interventional Radiology : JVIR·D A Diamond, T M Vesely
Nov 7, 1998·Current Problems in Cardiology·W H FrishmanM Weiss
Mar 24, 2000·The Journal of Surgical Research·J E FortunatoH S Bassiouny

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.